BioAtla, Inc. Common Stock (BCAB) is a publicly traded Healthcare sector company. As of May 21, 2026, BCAB trades at $3.62 with a market cap of $6.50M and a P/E ratio of -0.73. BCAB moved -3.36% today. Year to date, BCAB is -82.97%; over the trailing twelve months it is -81.51%. Its 52-week range spans $3.26 to $126.25. Rallies surfaces BCAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks BCAB insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.62 |
| Market Cap | $6.50M |
| P/E Ratio | -0.73 |
| EPS | $-4.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $126.25 |
| 52-Week Low | $3.26 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.00M |
| Net Income | $-50.62M |
| Gross Margin | 0.00% |
BCAB analyst coverage data. Average price target: $0.00.